openPR Logo
Press release

Gout Therapy Market by Application, Trends and Growth Rate to 2025

02-21-2018 01:17 PM CET | Health & Medicine

Press release from: Transparency Market Research

Gout Therapy Market by Application, Trends and Growth Rate

Gout is a chronic inflammatory disease characterized by swollen joints, pain, heat, redness, and joint stiffness. Gout starts with the inflammation of the big toe; however, it can affect several joints of the body such as ankles, heels, knees, wrists, fingers, and elbows. The disease is caused by the deposition of uric acid crystals in joints resulting in inflammation and pain. Other symptoms include increased level of uric acid in blood, uric acid deposition in joint fluids, and arthritis attacks. Diagnostic tests includes blood tests, synovial fluid testing analysis, and differential diagnosis testing.

View Report -

https://www.transparencymarketresearch.com/gout-therapy-market.html

Treatment of gout includes non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, colchicine-like drugs, and xanthine oxidase inhibitor. Xanthine oxidase inhibitor includes several drugs such as allopurinol and oxypurinol, which reduces uric acid production and helps control gout. According to an article published by the National Center for Biotechnology Information, gout is becoming more prevalent in United States, United Kingdom, New Zealand, and China. Another article published in the Springer Nature stated that the prevalence of this disease is more in developed countries as compared to other areas of the world.

It also stated that men are more prone to gout than women. In 2013, gout affected around 5.8 million people, contributing to nearly 1% to 2% of western population. Raising awareness regarding the disease in adult patients could be a profitable marketing opportunity for gout therapy drug manufacturers. The global gout therapy market will be majorly driven by new product launches during the forecast period. Few pipeline drug in the gout therapy market include PF-06743649 by Pfizer and Verinurad by AstraZeneca. Zurampic (lesinurad) by AstraZeneca received U.S regulatory approval in December 2015. The drug is used in combination with xanthine oxidase inhibitor. Entry of new drug therapies such as Uloric, Krystexxa, Colcrys, and Adenuric are expected to fuel the gout therapy market during the forecast period. Development of novel systemic treatment with enhanced safety and efficiency by drug manufactures is expected to boost the gout therapy market. Additionally, steadily rising pool of arthritic patients worldwide could impel the growth of the market.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=31529

The global gout therapy market has been segmented based on drug class, distribution channel, and region. Depending on type of drug therapy, the market has been classified into non-steroidal anti-inflammatory drugs, corticosteroids, colchicine-like drugs, xanthine oxidase inhibitor, and others. The Non-steroidal anti-inflammatory drugs are first-line treatment and are considered as a part of therapy, used to reduce pain caused by the inflammation. Colchicine-like drugs are considered to be second-line therapy, used in patients unable to tolerate NSAIDs.

Corticosteroids are injected into swollen joints and are as effective as non-steroidal anti-inflammatory drugs. Allopurinol, Probenecid, and Febuxostat are few other drugs used to reduce pain attacks caused by gout. New launch of combination therapy are expected to support the growth of the global gout therapy market. In terms of distribution channel the market has been categorized into hospitals, diagnostic centers, and clinics. Hospitals and clinics are expected to hold more share as compare to diagnostic centers.

Request to View ToC of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=31529

Based on geography, the global gout therapy market is segmented into five key regions: Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America and Europe are expected to dominate the market due to higher prevalence of gout in the regions. The Asia Pacific market is projected to hold second highest share in the market owing to rising prevalence of the disease in China and India. China is estimated to account for the largest share of the gout therapeutics market owing to factors such as improvement in diagnosis rate, growing geriatric population, and increasing arthritic patient pool.

Major players involved in the global gout therapy market include AstraZeneca plc., Boehringer Ingelheim GmbH, Teijin Pharma Ltd., Regeneron Pharmaceuticals, GlaxoSmithKline plc., Merck & Co. Inc., Novartis AG, and Savient Pharmaceuticals.

Enquiry for discount on this report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=31529

About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gout Therapy Market by Application, Trends and Growth Rate to 2025 here

News-ID: 952179 • Views: 112

More Releases from Transparency Market Research

Wearable EEG Devices Market: Growing incidences of Neurovascular Disorders is Dr …
According to new market research titled 'Wearable EEG Devices Market to 2027 - Global Analysis and Forecasts by Channel and Application.' The global wearable EEG devices market is expected to reach US$ 1,556.35 Mn in 2027 from US$ 745.05 Mn in 2018. The market is projected to grow with a CAGR of 8.7% from 2019-2027. The report provides trends prevailing in the global wearable EEG devices market and the factors
Decentralized Electricity Generation Market - Global Industry Analysis, Share, G …
Global Decentralized Electricity Generation Market: Overview With the increasing installation of smart grids and the rising number of electricity generation resources, the power generation industry has been undergoing a significant change over the recent past. The modification in the grid structure, which permits decentralization of electricity generation, is acting as the main driving force behind the substantial growth of the global market for decentralized electricity generation. The main objective of this research
Global Sucralose Market Outlook In The Developed And Emerging Industry
Sucralose Market Overview Sugar substitute market is witnessing an increasing demand driven by the increasing sales of various sugar substitutes such as natural sweeteners and artificial sweeteners. Sucralose, an artificial sweetener used as a sugar substitute is highly preferred by consumers owing to its zero calorie attribute. Though sucralose is 600 times sweeter than sugar but interestingly it is not identified as the carbohydrate by the human body. Sucralose has its
Flavored Syrup Market - Growth Powered with Latest Development Scenario & Influe …
Flavored Syrup Market Introduction Global syrup market is witnessing a significant demand generated by the food and beverage industry. Consumers' increasing preference for different and personalized flavors in food has driven the syrup manufacturers to produce a wide range of flavored syrups. Flavored syrups contain artificial or natural flavorings mixed along with sugar and water. Obtain Report Details @ https://www.transparencymarketresearch.com/flavored-syrup-market.html Increasing demand of flavored syrups especially among the consumers contributes to the

All 5 Releases


More Releases for Gout

Gout Therapeutics Market Is Booming Worldwide | Takeda Pharmaceutical Company, N …
HTF MI recently introduced Global Gout Therapeutics Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are Takeda Pharmaceutical Company, Novartis, AstraZeneca, GlaxoSmithKline, Merck & Regeneron Pharmaceuticals etc.
Gout Therapeutics Market - Growth Management 2017-2025
Global Gout Therapeutics Market: Snapshot The objective of treatment during a severe gout attack involves suppressing inflammation and controlling pain. The treatment of inflammation and pain can be attained with non-steroidal anti-inflammatory drugs, colchicine, or corticosteroids. The line of treatment chosen that would be suitable depends on the co-morbid medical conditions of the patient, side effect profile, and other medications. Request Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=2549 Patients with multiple episodes of
Gout Therapeutics Market Moderately consolidated by 2025
Global Gout Therapeutics Market: Snapshot The objective of treatment during a severe gout attack involves suppressing inflammation and controlling pain. The treatment of inflammation and pain can be attained with non-steroidal anti-inflammatory drugs, colchicine, or corticosteroids. The line of treatment chosen that would be suitable depends on the co-morbid medical conditions of the patient, side effect profile, and other medications. Patients with multiple episodes of severe gout attacks every year or with
Gout Therapeutics Market - High Growth Rate Foreseen during 2017 - 2025
Global Gout Therapeutics Market: Snapshot The objective of treatment during a severe gout attack involves suppressing inflammation and controlling pain. The treatment of inflammation and pain can be attained with non-steroidal anti-inflammatory drugs, colchicine, or corticosteroids. The line of treatment chosen that would be suitable depends on the co-morbid medical conditions of the patient, side effect profile, and other medications. Patients with multiple episodes of severe gout attacks every year or with
Gout Therapeutics Market - Future Growth & Forecast 2017-2025
Global Gout Therapeutics Market: Overview Gout is a physical conditions that affects the patient’s ability to move, often also termed as unwalkable disease, and it has been around for centuries. But in the recent times, especially in the U.S., the prevalence of gout has increased to greater extents, which is a reflection of growing population with obesity, smoking habits, and increased intake of alcohol. Increased level of uric acid in the
Gout Therapeutics - Emerging Markets in Developing Countries
Qyresearchreports include new market research report Gout Therapeutics to its huge collection of research reports. The global market for Gout Therapeutics is discussed in detail within a new research study added recently to QYResearchReports.com. The report has been carefully examined both qualitatively and quantitatively and the results are revealed in the research report for the forecast period of 2017 to 2022. In addition to this, the various drivers and restraints, regulatory